MACHINE LEARNING IN THE DIAGNOSIS AND PROGNOSTIC ASSESSMENT OF ACUTE MYELOID LEUKEMIA

Authors

  • Mavlonkhonova Odinakhon Author
  • Tokhtayeva Sitora Akmalovna Author

Keywords:

Acute Myeloid Leukemia, machine learning, diagnosis, prognosis, artificial intelligence, deep learning, predictive modeling

Abstract

Acute Myeloid Leukemia (AML) is a heterogeneous hematological malignancy characterized by the uncontrolled proliferation of immature myeloid cells in the bone marrow and peripheral blood. Early diagnosis and accurate prognostic assessment are essential for selecting appropriate treatment strategies and improving patient survival. Machine learning enables the analysis of complex clinical, laboratory, genomic, and imaging data with high predictive accuracy. This study investigates the application of machine learning models in the diagnosis and prognostic assessment of AML. The findings demonstrate that advanced machine learning algorithms improve diagnostic accuracy, relapse prediction, and individualized risk stratification.

References

1. Döhner H., Wei A.H., Appelbaum F.R. Diagnosis and management of acute myeloid leukemia in adults. Blood, 2022.

2. Short N.J., Rytting M.E., Cortes J.E. Acute Myeloid Leukaemia. The Lancet, 2018.

3. Papaemmanuil E., Gerstung M., Bullinger L. Genomic Classification and Prognosis in Acute Myeloid Leukemia. New England Journal of Medicine, 2016.

4. Arber D.A., Orazi A., Hasserjian R. The 2022 WHO Classification of Myeloid Neoplasms and Acute Leukemia. Leukemia, 2022.

5. Kourou K., Exarchos T.P., Exarchos K.P. Machine Learning Applications in Cancer Prognosis and Prediction. Computational and Structural Biotechnology Journal, 2015.

Published

2026-09-25